ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013